Drugs

Camurus Announces Strong First Quarter Demand for Buvidal®

Retrieved on: 
Thursday, April 2, 2020
Psychoactive drugs, RTT, Morphine, Drugs, Organizations, Camurus, Lund, Opioids, Substance dependence, Opioid use disorder, Heroin, European Union

Lund, Sweden, April 2, 2020 /PRNewswire/ -- Camurus announced today continued strong revenue growth driven by increasing demand for weekly and monthly Buvidal for the treatment of opioid dependence in EU and Australia.

Key Points: 
  • Lund, Sweden, April 2, 2020 /PRNewswire/ -- Camurus announced today continued strong revenue growth driven by increasing demand for weekly and monthly Buvidal for the treatment of opioid dependence in EU and Australia.
  • "We see a large and growing interest in Buvidal across markets and a strong increase in the number of patients receiving treatment with Buvidal in Europe and Australia.
  • "As a company, Camurus stands strong at a challenging time and we look forward to sharing our first quarter results on 7 May 2020," says Fredrik Tiberg.
  • This is information is information that Camurus AB is obliged to make public pursuant to the EU Market Abuse Regulation.

Arena Pharmaceuticals Announces Positive Topline Data for New Development Program - Etrasimod Controlled-Release (CR)

Retrieved on: 
Wednesday, April 1, 2020
Drugs, Psychoactive drugs, Neurochemistry, RTT, Chloroarenes, Euphoriants, Calcium channel blockers, Amines, Ketamine

At additional measurements over 24 hours, the etrasimod CR heart rate effect was reduced or similar compared to etrasimod.

Key Points: 
  • At additional measurements over 24 hours, the etrasimod CR heart rate effect was reduced or similar compared to etrasimod.
  • Of note, the rate of change in heart rate was reduced greater than 50% with etrasimod CR delivery.
  • "Etrasimod currently has a potential best-in-class profile as a rapid-acting, non-titrated oral therapy with limited first-dose heart rate effect.
  • It is exciting that Arena's etrasimod CR program has the potential to further differentiate this profile," stated Preston Klassen, MD, MHS, Executive Vice President, Research and Development at Arena.

Zymeworks Announces First Patient Dosed in Phase 1b/2 Trial of ZW25 in First-Line HER2-Positive Breast Cancer and Gastroesophageal Adenocarcinoma Conducted by BeiGene

Retrieved on: 
Wednesday, April 1, 2020
Biotechnology, Health, Pharmaceutical, Clinical trials, Oncology, Drugs, Cancer treatments, Chemistry, Carbamates, Docetaxel, RTT, Sanofi, Taxanes, Monoclonal antibodies, ZW25, the Zymeworks-BeiGene Collaboration, Zymeworks Inc.

Zymeworks will receive a payment under its collaboration with BeiGene as a result of the achievement of this development milestone.

Key Points: 
  • Zymeworks will receive a payment under its collaboration with BeiGene as a result of the achievement of this development milestone.
  • We look forward to the results of these trials, which have the potential to further expand the population of patients who may benefit from ZW25.
  • Arm one of the trial will evaluate the safety, tolerability, and preliminary antitumor activity of ZW25 in combination with docetaxel in patients with metastatic HER2positive breast cancer.
  • Zymeworks lead clinical candidate, ZW25, is a novel Azymetric bispecific antibody currently in Phase 2 clinical development.

qemp™ launches qemp ZERO, THE sustainable choice in hemp seed oil

Retrieved on: 
Wednesday, April 1, 2020
Drugs, Euphoriants, Organ systems, Entheogens, Appetite stimulants, Biofuels, Hemp, Herbs, Cannabidiol, Cannabis, Cannabinoid, Tetrahydrocannabinol

Available in all 50 states, qemp ZERO hemp seed oil offers a safe, natural extension of the qemp product line.

Key Points: 
  • Available in all 50 states, qemp ZERO hemp seed oil offers a safe, natural extension of the qemp product line.
  • The qemp ZERO products are made from quality, whole spectrum hemp extract to provide a full profile of phytocannabinoids and contain 0.3% THC or less.
  • About qemp:Powered by Nature's Sunshine Products, the qemp product line is THE premium quality, hemp-derived CBD oil on the market along with additional product extensions including qemp ZERO.
  • qemp ZERO offers hemp seed oil as a safe and natural extension of the product line without THC* or CBD*.

Jessica Billingsley to Participate in Expert Webcast

Retrieved on: 
Wednesday, April 1, 2020
Cannabis smoking, Psychoactive drugs, Cannabis, Entheogens, Euphoriants, Effects of cannabis, Health, Drugs

DENVER, April 01, 2020 (GLOBE NEWSWIRE) -- Jessica Billingsley, CEO, Akerna, (Nasdaq: KERN), a leading compliance technology provider and developer of the cannabis industrys first seed-to-sale enterprise resource planning (ERP) software technology (MJ Platform), will join with other leading experts in an Expert Webcast virtual roundtable addressing: The Impact of COVID-19 on the Cannabis Industry.

Key Points: 
  • DENVER, April 01, 2020 (GLOBE NEWSWIRE) -- Jessica Billingsley, CEO, Akerna, (Nasdaq: KERN), a leading compliance technology provider and developer of the cannabis industrys first seed-to-sale enterprise resource planning (ERP) software technology (MJ Platform), will join with other leading experts in an Expert Webcast virtual roundtable addressing: The Impact of COVID-19 on the Cannabis Industry.
  • The webcast is Thursday, April 2, at 4 p.m.
  • The panel will discuss the acute and ongoing issues the pandemic is causing as well as how the industry will likely emerge.
  • Topics will include the impact of shelter-in-place orders, labor and employment issues, challenges to operations and liquidity, insurance and contractual considerations, restructuring without federal bankruptcy and the crisis impact on federal and state bills.

Surgical Tourniquets Market (2019 to 2023) - Global Forecast and Analysis - ResearchAndMarkets.com

Retrieved on: 
Wednesday, April 1, 2020
Medical Supplies, Health, Psychoactive drugs, Medical equipment, Drugs, Blood, Tourniquet, Articles, RTT, Surgery, Heroin, Market analysis

The "Surgical Tourniquets Market by Product and Geography - Global Forecast and Analysis 2019-2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Surgical Tourniquets Market by Product and Geography - Global Forecast and Analysis 2019-2023" report has been added to ResearchAndMarkets.com's offering.
  • The surgical tourniquets market analysis considers sales from both pneumatic tourniquets and non-pneumatic tourniquets.
  • Factors such as technological advancements in pneumatic surgical tourniquets will play a significant role in the pneumatic tourniquets segment to maintain its market position.
  • However, high costs associated with orthopedic surgeries, product recalls, and complications associated with surgical tourniquets may hamper the growth of the surgical tourniquets industry over the forecast period.

Two Bears Farm Affirms Hemp Cannabinoid and Terpene Studies - Stress and Anxiety Can Put Even More Strain Upon Our Immune Systems

Retrieved on: 
Wednesday, April 1, 2020
Entheogens, Euphoriants, Appetite stimulants, Drugs, Crops, Medicinal plants, Psychoactive drugs, Herbs, Cannabinoid, Hemp, Cannabis, Tetrahydrocannabinol

PHOENIX, April 1, 2020 /PRNewswire/ --Two Bears Farm ( https://www.twobears.farm/ ) recently affirmed studies using high-CBD smokable products in the treatment of chronic anxiety.

Key Points: 
  • PHOENIX, April 1, 2020 /PRNewswire/ --Two Bears Farm ( https://www.twobears.farm/ ) recently affirmed studies using high-CBD smokable products in the treatment of chronic anxiety.
  • Founded by USMC veteran Sara Sheeler, Two Bears Farm curates premium, hand-cultivated and cured hemp with very high terpene and cannabinoid levels (including CBD) that is -compliant ( 0.3% THC).
  • Smokable Hemp: The Benefits of Cannabinoids and Terpenes on Stress, Anxiety and Sleep
    The 2018 study performed by Washington State University is the first of its kind in the U.S..
  • Durango, CO-based Two Bears Farm is known for its 100% smokable hemp pre-rolls with rare terpene levels of up to 6%.

bestmarijuanaguide.com Announces Launch of Cannabis Directory and Reviews on April 1st, 2020

Retrieved on: 
Wednesday, April 1, 2020
Cannabis, Cannabis smoking, Entheogens, Euphoriants, Legality of cannabis, Drugs, Psychoactive drugs

DENVER, April 1, 2020 /PRNewswire/ --bestmarijuanaguide.com, the premier online directory for cannabis products, suppliers, and dispensaries has announced it launch on the morning of April 1st, 2020.

Key Points: 
  • DENVER, April 1, 2020 /PRNewswire/ --bestmarijuanaguide.com, the premier online directory for cannabis products, suppliers, and dispensaries has announced it launch on the morning of April 1st, 2020.
  • The website serves as an online resource for those looking for exceptional brands in the cannabis space and other helpful resources.
  • Buyers can recount their experiences and offer insight into each of the brands featured in the rankings on bestmarijuanaguide.com.
  • Brands working within the cannabis industry interested in proving their merit can register directly from the homepage: https://www.bestmarijuanaguide.com/#rp
    bestmarijuanaguide.com is the premier provider of reviews and resources within the cannabis industry.

Blueberries Medical Provides Corporate Update

Retrieved on: 
Wednesday, April 1, 2020
Entheogens, Euphoriants, Medicinal plants, Medicine, Drugs, Herbalism, Appetite stimulants, Health, Cannabis, Medical cannabis, Tetrahydrocannabinol, Legality of cannabis

TORONTO, April 01, 2020 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the Company or Blueberries), a Latin American producer of medicinal cannabis and cannabis-derived products, is providing the following update on the Companys recent operating activities.

Key Points: 
  • TORONTO, April 01, 2020 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the Company or Blueberries), a Latin American producer of medicinal cannabis and cannabis-derived products, is providing the following update on the Companys recent operating activities.
  • In view of the COVID-19 pandemic, we would like to provide an update on our activities at Blueberries.
  • Blueberries is fully licensed for the cultivation, production, domestic distribution, and international export of CBD and THC-based medical cannabis in Colombia.
  • The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.

HempMeds®, Subsidiary of Medical Marijuana, Inc., Expands Popular CBD Oil Tincture Line with Two New Flavors

Retrieved on: 
Tuesday, March 31, 2020
Drugs, Organ systems, Analgesics, Anticonvulsants, Cannabidiol, Cannabinoids, Resorcinols, Psychoactive drugs, Cannabis

Dixie Botanicals Dew Drops CBD Oil Tinctures, including the new strawberry and tangerine flavors, are naturally flavored and formulated for rapid absorption when taken under the tongue.

Key Points: 
  • Dixie Botanicals Dew Drops CBD Oil Tinctures, including the new strawberry and tangerine flavors, are naturally flavored and formulated for rapid absorption when taken under the tongue.
  • Each one-ounce bottle offers 250 mg of CBD while the two-ounce bottle provides a total of 500 mg of CBD.
  • Dixie Botanicals Dew Drops CBD Oil Tinctures come with a convenient dropper to easily measure intake and are packaged in an amber bottle to preserve freshness.
  • Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.'s shop.